What are the recommended valacyclovir (Valtrex) dosing regimens for primary, recurrent, and suppressive treatment of oral herpes, including adjustments for renal impairment?

Valacyclovir Treatment for Oral Herpes

For oral herpes (herpes labialis), use valacyclovir 2 grams twice daily for 1 day (two doses separated by 12 hours), initiated at the earliest prodromal symptom. 1

Treatment Regimens

Acute/Episodic Treatment

The FDA-approved regimen for cold sores is straightforward and highly effective:

• 2 grams twice daily for 1 day (12 hours apart)
• Start at first sign of prodrome (tingling, itching, burning)
• This single-day regimen reduces median episode duration to 4.0-5.0 days versus 5.0 days with placebo 2

This high-dose, short-duration approach is superior to older acyclovir regimens and provides the convenience of completing treatment in just one day.

Suppressive Therapy

For patients with frequent recurrences (≥4 episodes per year):

• 1 gram once daily for chronic suppression 1
• Significantly reduces recurrence frequency: 60% of patients remain recurrence-free versus 38% with placebo 2, 3
• Prolongs time to first recurrence: median 13.1 weeks versus 9.6 weeks with placebo 3
• Reduces mean number of recurrences per 120 days from 0.71 to 0.30 4

Suppressive therapy is more effective than episodic treatment for patients with frequent recurrences, reducing recurrence frequency by approximately 50-60% 4, 3.

Renal Dose Adjustments

Critical caveat: Valacyclovir overdosing in renal impairment causes preventable neurotoxicity and occurs in 25% of prescriptions for patients with impaired renal function 5, 6. Always calculate creatinine clearance before prescribing.

Dosing by Creatinine Clearance (CrCl)

For Cold Sores (Herpes Labialis):

• CrCl ≥50 mL/min: 2 grams twice daily for 1 day (no adjustment)
• CrCl 30-49 mL/min: 1 gram every 24 hours (do not exceed 1 day)
• CrCl 10-29 mL/min: 500 mg every 24 hours (do not exceed 1 day)
• CrCl <10 mL/min: 500 mg every 24 hours (do not exceed 1 day)

For Suppressive Therapy:

• CrCl ≥50 mL/min: 1 gram every 24 hours (no adjustment)
• CrCl 30-49 mL/min: 500 mg every 24 hours
• CrCl 10-29 mL/min: 500 mg every 24 hours
• CrCl <10 mL/min: 500 mg every 24 hours

1

Hemodialysis Patients

• Administer the recommended dose after hemodialysis
• Approximately one-third of acyclovir is removed during a 4-hour dialysis session
• No supplemental doses needed for peritoneal dialysis (CAPD/CAVHD) 1

Critical Safety Considerations

Neurotoxicity Risk

Valacyclovir and acyclovir carry higher CNS disturbance risk than famciclovir, particularly in renal dysfunction 7:

• Risk difference versus famciclovir: 0.33% for acyclovir (NNH 278), 0.12% for valacyclovir (NNH 833)
• In dialysis patients, CNS disturbance incidence reaches 2.29% with acyclovir/valacyclovir versus 0.60% with famciclovir 7
• Manifestations include confusion, hallucinations, tremors, seizures 6

If neurotoxicity occurs: Stop valacyclovir immediately and consider emergent hemodialysis in severe cases, as the half-life extends to 14 hours in ESRD 6.

Acute Renal Failure

Cases reported particularly in:

• Elderly patients (even with normal baseline renal function)
• Patients receiving higher-than-recommended doses for their renal function 1
• Pregnant women receiving high-dose therapy (approximately 1% risk) 8

Pediatric Dosing

For patients ≥12 years: Same as adult dosing (2 grams twice daily for 1 day) 1

Common Prescribing Errors to Avoid

1. Failure to adjust for renal function: Occurs in 25% of prescriptions for patients with impaired renal function, especially for high-dose indications 5
2. Prescribing multi-day courses for cold sores: The approved regimen is 1 day only
3. Not calculating CrCl in elderly patients: Age-related renal decline necessitates dose adjustment even with "normal" creatinine
4. Continuing therapy despite neurological symptoms: Stop immediately if confusion, tremors, or altered mental status develop